2011—2014年吉林大学第一医院抗肿瘤中药注射剂的使用情况分析

Analysis on utilization of anti-tumor TCM injections in the First Hospital of Jilin University from 2011 to 2014

目的分析吉林大学第一医院抗肿瘤中药注射剂的应用情况及变化趋势,为临床合理用药提供参考。方法调取2011—2014年吉林大学第一医院抗肿瘤中药注射剂的使用数据,采用用药频度(DDDs)、日均费用(DDC)及药物利用指数(DUI)等药物利用指标进行回顾性分析。结果 2011—2014年抗肿瘤中药注射剂的用药金额呈逐年上升趋势,品种基本稳定;4年来艾迪注射液的DDDs居首位,DDC基本稳定不变,并且DDC值均较高;消癌平注射液的DUI居首位;抗肿瘤中药注射剂的不良反应发生较少。结论吉林大学第一医院抗肿瘤中药注射剂的应用基本合理,呈不断增长趋势,应加强监管,保证合理、安全使用。

Objective To analyze utilization and trend of anti-tumor traditional Chinese medicine（TCM） injections in the First Hospital of Jilin University, to provide reference for clinical rational use. Methods The utilization of anti-tumor TCM injections in the First Hospital of Jilin University from 2011 to 2014 was selected, and defined daily doses（DDDs）, daily drug cost（DDC）, and drug utility index（DUI） were analyzed statistically. Results From 2011 to 2014, the consumption sum of anti-tumor TCM Injections increased year by year. The types of anti-tumor TCM injections were stable. Aidi Injection took the lead in terms of DDDs over the 4 years. DDC was stable and high. Xiaoaiping Injection took the lead in terms of DUI over the 4 years. There were less adverse reactions in anti-tumor TCM injections. Conclusion The utilization of anti-tumor TCM injections in the First Hospital of Jilin University is reasonable basically, and increases year by year. Supervision on rational use of anti-tumor TCM injections should be strengthened to ensure rational and safe use of anti-tumor TCM injections.